DENTSPLY SIRONA Q2 EPS Estimate Decreased by William Blair

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) – Investment analysts at William Blair reduced their Q2 2025 earnings per share (EPS) estimates for shares of DENTSPLY SIRONA in a report released on Thursday, February 27th. William Blair analyst B. Vazquez now forecasts that the medical instruments supplier will post earnings of $0.44 per share for the quarter, down from their prior forecast of $0.52. The consensus estimate for DENTSPLY SIRONA’s current full-year earnings is $1.84 per share. William Blair also issued estimates for DENTSPLY SIRONA’s Q3 2025 earnings at $0.51 EPS, FY2025 earnings at $1.80 EPS, Q2 2026 earnings at $0.47 EPS, Q3 2026 earnings at $0.54 EPS, Q4 2026 earnings at $0.61 EPS and FY2026 earnings at $1.93 EPS.

Other equities research analysts have also issued reports about the company. Mizuho began coverage on DENTSPLY SIRONA in a research report on Wednesday, December 4th. They set a “neutral” rating and a $21.00 target price for the company. Leerink Partnrs downgraded DENTSPLY SIRONA from a “strong-buy” rating to a “hold” rating in a report on Thursday, November 7th. Jefferies Financial Group downgraded DENTSPLY SIRONA from a “buy” rating to a “hold” rating and cut their price target for the company from $30.00 to $20.00 in a report on Thursday, January 23rd. Wells Fargo & Company cut their price target on DENTSPLY SIRONA from $20.00 to $19.00 and set an “equal weight” rating on the stock in a report on Friday, February 28th. Finally, Needham & Company LLC cut their price target on DENTSPLY SIRONA from $25.00 to $23.00 and set a “buy” rating on the stock in a report on Friday, February 28th. Eleven research analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. Based on data from MarketBeat, DENTSPLY SIRONA has a consensus rating of “Hold” and a consensus target price of $23.58.

DENTSPLY SIRONA Trading Down 2.5 %

Shares of NASDAQ XRAY opened at $15.59 on Monday. The company has a quick ratio of 0.84, a current ratio of 1.25 and a debt-to-equity ratio of 0.72. The business has a fifty day simple moving average of $18.77 and a two-hundred day simple moving average of $21.39. The firm has a market cap of $3.10 billion, a PE ratio of -7.53, a price-to-earnings-growth ratio of 1.80 and a beta of 0.96. DENTSPLY SIRONA has a twelve month low of $15.47 and a twelve month high of $34.28.

DENTSPLY SIRONA Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, April 11th. Investors of record on Friday, March 28th will be paid a dividend of $0.16 per share. The ex-dividend date of this dividend is Friday, March 28th. This represents a $0.64 annualized dividend and a yield of 4.11%. DENTSPLY SIRONA’s dividend payout ratio (DPR) is -14.07%.

Insider Buying and Selling

In other news, Director Gregory T. Lucier purchased 15,142 shares of the stock in a transaction on Monday, March 3rd. The stock was bought at an average price of $16.51 per share, with a total value of $249,994.42. Following the transaction, the director now owns 81,971 shares in the company, valued at $1,353,341.21. The trade was a 22.66 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.52% of the stock is owned by company insiders.

Institutional Trading of DENTSPLY SIRONA

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Capital Performance Advisors LLP acquired a new stake in DENTSPLY SIRONA during the 3rd quarter worth about $27,000. Kennebec Savings Bank acquired a new stake in DENTSPLY SIRONA during the 3rd quarter worth about $35,000. Colonial Trust Co SC acquired a new stake in DENTSPLY SIRONA during the 4th quarter worth about $26,000. Riverview Trust Co acquired a new stake in DENTSPLY SIRONA during the 4th quarter worth about $26,000. Finally, MassMutual Private Wealth & Trust FSB lifted its position in DENTSPLY SIRONA by 648.4% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 1,422 shares of the medical instruments supplier’s stock worth $27,000 after acquiring an additional 1,232 shares during the period. Institutional investors and hedge funds own 95.70% of the company’s stock.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.